DCM
IRWD icon

Driehaus Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Driehaus Capital Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-210,054
Closed -$1.83M – 411
2024
Q1 		$1.83M Sell
210,054
-1,372,080
-87% -$16.6M 0.02% 309
2023
Q4 		$18.1M Sell
1,582,134
-4,631
-0.3% -$45.8K 0.22% 148
2023
Q3 		$15.3M Sell
1,586,765
-1,212
-0.1% -$11.9K 0.2% 162
2023
Q2 		$16.9M Buy
+1,587,977
New +$17.1M 0.21% 155

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Driehaus Capital Management's IRWD Position: Q2 2024 in Review

Driehaus Capital Management sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2024, closing a stake of 210,054 shares — an estimated $1.83M sold.

Driehaus Capital Management first reported a position in IRWD in Q2 2023 and held it in 4 quarters. The position peaked at $18.1M in Q4 2023. 226 funds tracked by Wall St. Rank hold IRWD as of Q2 2024.

  • Driehaus Capital Management reported no remaining Ironwood Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Driehaus Capital Management sold 210,054 Ironwood Pharmaceuticals shares in Q2 2024, an estimated $1.83M.
  • Driehaus Capital Management first reported a position in Ironwood Pharmaceuticals in Q2 2023 and held it in 4 quarters.
  • Driehaus Capital Management's Ironwood Pharmaceuticals position peaked at $18.1M in Q4 2023.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2024.

Based on Driehaus Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.